Haisco Pharmaceutical Group Co Ltd, a China-based company focused on the research and development and marketing of thera...
Synergy Pharmaceuticals recently announced that the company has entered into a license agreement with Luoxin Pharm...
JHL Biotech has received a positive Scientific Advice from the Committee for Medicinal Products for Human Use (CHMP) of ...
EdiGene Inc., which develops genome editing technologies into novel therapeutics for a broad range of diseases and into ...
Australian and Chinese scientists have developed a method using coded nanoparticles to detect and help diagnose disease....
Ascletis Pharma Inc announced Ravidasvir is recommended by the World Health Organization (WHO) Guidelin...
On August 8, 2018, Beijing time I-Mab Biopharma ("I-Mab"), a Shanghai-based biotech company focused on innovative biolog...
Pfizer China announced that the China National Drug Administration (CNDA) has granted approval of IBRANCE® (palbocic...
Glenmark Pharmaceuticals S.A. and Harbour BioMed have entered into an exclusive license agreement for the Greater C...
Cure Genetics Co., Ltd., a biotechnology company dedicated to the development of life-saving transformative medicines an...
IMPACT Therapeutics a China-based clinical-stage biopharmaceutical company dedicated to the discovery and development of...
Laekna Inc., a biotechnology company headquartered in Shanghai has announced the signing of an agreement with Novartis P...
Legend Capital, the venture and growth capital arm of China’s Legend Holdings Ltd, has co-led an RMB2 billion ($29...
Chinese medical solution provider Medlinker has raised a RMB1 billion ($146.8 million) series D round led by China Capit...
Ascletis has received the acceptance letter from the China Food and Drug Administration (CFDA) for Ravidasvir (RDV) new ...
Orig3n, Inc., a Boston-based biotech company pioneering the future of health through genetics and regenerative medicine,...
Ascletis announced that the Ganovo phase III clinical study won the top clinical research award at the 15th National Con...
Shanghai-based biopharma firm Curon Biopharmaceutical has announced the completion of its Series A funding round, which ...
